Family Medicine Doctors in New Martinsville, WV Accepting Medicare

6 Family Medicine doctors found. Showing 1 - 6

Amanda Diane Nichols, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3 E Benjamin Dr, New Martinsville, WV 26155 Phone: 304-455-8080    Fax: 304-455-8141

Jessica Maria Lewis, FNP-C Family Medicine Medicare: Medicare Enrolled Practice Location: 225 Russell Ave, New Martinsville, WV 26155 Phone: 304-455-2600

Mr. Edward Lee Emch, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 261 Monroe Ave, New Martinsville, WV 26155 Phone: 304-455-4944    Fax: 304-455-4968

Dr. Donald Alan Blum, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3 E Benjamin Dr Ste B, New Martinsville, WV 26155 Phone: 304-455-8082

Gary A Nichols, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3 E Benjamin Dr, New Martinsville, WV 26155 Phone: 304-455-8080    Fax: 304-455-8141

Holly Noel Young, MSN FNP-BC Family Medicine Medicare: Medicare Enrolled Practice Location: 3 E Benjamin Dr, New Martinsville, WV 26155 Phone: 740-525-0135    Fax: 304-455-8021

News Archive

Study shows that different brain regions process different types of fear

What do bullies and sex have in common? Based on work by scientists at the European Molecular Biology Laboratory (EMBL) in Monterotondo, Italy, it seems that the same part of the brain reacts to both.

Obama 'comfortable' with morning-after pill sales at 15

President Barack Obama said he is "very comfortable" with the Food and Drug Administration rule announced this week to make the so-called morning after pill available without a prescription to women and girls who are at least 15 - younger than the current limit of 17.

Scientists develop model that makes real-life stock buying behavior comprehensible

Despite long-term profit expectations, many Germans shy away from investing their money in supposedly riskier forms of investment. Why?

Gilead's Quad Phase 3 clinical study in treatment-naïve HIV-1 patients meets 48-week primary objective

Gilead Sciences, Inc. today announced that the second pivotal Phase 3 clinical trial of its investigational fixed-dose, single-tablet "Quad" regimen of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate, being evaluated for HIV-1 infection in treatment-naïve patients, met its primary objective of non-inferiority at week 48 as compared to ritonavir-boosted atazanavir plus Truvada.

Read more Medical News

› Verified 2 days ago